personal info Dr. Gardner has been at Certara since 2011. He leads the science team that is responsible for further developments of the population-based physiologically-based PK/PD simulators to meet the needs of Simcyp Consortium members. Prior to joining...

personal info Hannah Jones, PhD, serves as the Senior Vice President of PBPK Consultancy Services at Certara. With over 20 years of experience in global pharmaceutical organizations, she boasts a particularly robust background in PBPK and PKPD modeling. Dr....

personal info With a career spanning more than 30 years in the pharmaceutical industry, Steve Sibley provides regulatory writing consulting services and leads the global submissions service line within Certara Drug Development Solutions (CDDS). He has led...

personal info Amitava is Executive Director and Head of Clinical Pharmacology at Kura Oncology, where he supports global drug development programs. He has 17 years of experience in the pharmaceutical industry supporting various therapeutic areas and has...

personal info Jennypher Mudunuru, Ph.D., is an accomplished Modeling Scientist specializing in Drug Metabolism and Pharmacokinetics (DMPK) at GlaxoSmithKline (GSK). With a robust foundation in pharmacokinetics and expertise in DMPK and Absorption,...

personal info Dr Karen Rowland Yeo is Senior Vice-President, Client & Regulatory Strategy at Certara UK Ltd. She has over two decades of experience of applying PBPK models in both global health and drug development settings across most therapeutic areas...

AgendaLocationRegister document.addEventListener("DOMContentLoaded", function() { document.querySelector(".wgl-logotype-container.logo-mobile...

AgendaLocationRegister document.addEventListener("DOMContentLoaded", function() { document.querySelector(".wgl-logotype-container.logo-mobile...

AgendaLocationRegister document.addEventListener("DOMContentLoaded", function() { document.querySelector(".wgl-logotype-container.logo-mobile...

personal info Demetrius Carter, RAC, is a clinical development executive with 20+ years of drug development experience in both the pharmaceutical and medical device industries. His experience includes roles at Glaxo SmithKline, Pfizer and JNJ before...